Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26160213 | 0.80 | GABRA1 (0.34) | LMNAHPGD | |
| SCHEMBL4777972 | 0.77 | ADRA2C (0.34) | KDM4EMEN1ALDH1A1LMNAGAA | |
| Iodide SCHEMBL7792123 | 0.76 | ADRA2C (0.33) | KDM4EMEN1ALDH1A1LMNAGAA | |
| SCHEMBL27264458 | 0.74 | KDM4E (0.32) | KDM4EMEN1ALDH1A1LMNAGAA | |
| SCHEMBL26597046 | 0.73 | KDM4E (0.30) | KDM4EMEN1ALDH1A1LMNAGAA | |
| SCHEMBL26633949 | 0.73 | SLC6A2 (0.31) | LMNA | |
| SCHEMBL1128432 | 0.72 | HDAC3 (0.35) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| Iodide SCHEMBL10822526 | 0.70 | HDAC3 (0.35) | MEN1KMT2A | |
| SCHEMBL27678947 | 0.70 | CRBN (0.30) | KDM4EMEN1ALDH1A1LMNAGAA | |
| Bromide SCHEMBL7991329 | 0.69 | PARP1 (0.34) | MEN1ALDH1A1LMNAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | CAT, MPO, NISCH | KDM4E 4759/4885MEN1 2920/4885ALDH1A1 2110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.